Acumen Pharmaceuticals is developing an Alzheimer’s disease drug that it believes offers advantages compared to other approaches—including the recently approved Biogen therapy. A small clinical trial ...

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted ...

Forbes contributors publish independent expert analyses and insights. Anne Field covers impact entrepreneurship and impact investing. A few years ago, Acumen, the pioneering patient capital impact ...

Acumen Pharmaceuticals has early clinical evidence that its Alzheimer’s disease candidate safely reduces amyloid plaque. But while the readout partly addresses concerns about the molecule’s activity, ...

Acumen and JCR aim to develop a product leveraging Acumen’s amyloid beta oligomer-selective antibody expertise and JCR’s transferrin-receptor-targeting blood-brain barrier-penetrating technology ...

NEWTON, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid ...

If leadership is devoid of strategic acumen then the country can never be stable, prosperous and strong. Strategic acumen is a major requirement for a country like Pakistan which has passed through ...

The average American household uses 11,000 kilowatthours of power each year. And yet around the world half a billion people still live without electricity. The deprivation is most acute in sub-Saharan ...

Beauparc, which is owned by private equity firm Macquarie Asset Management, says the Acumen purchase for an undisclosed sum “reinforces” its efforts to become a complete in-house total waste ...

In a company, a manager seen as having general business acumen is one who consistently exercises sound judgment – the results of his decisions are most often favorable. Those he works with would say ...